Clinical Trial Update: Impact of Fatty Liver on Hepatitis B Therapy

View source ↗

Summary

The trial assesses whether fatty liver disease influences hepatitis B antiviral therapy. It is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Tianjin Second People's Hospital | Conditions: Fatty Liver Disease, Chronic Hepatitis B | Status: ACTIVE_NOT_RECRUITING